Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
BMC Musculoskelet Disord ; 23(1): 471, 2022 May 19.
Article in English | MEDLINE | ID: covidwho-1951165

ABSTRACT

OBJECTIVES: To determine the prevalence and characteristics of post-COVID-19 (PC) in fibromyalgia (FM) patients. METHODS: Retrospective, multi-centric, observational study, comparing a group of FM patients (FM group) with another group of patients with other rheumatic diseases (RD group). COVID-19 diagnosis was established by positive polymerase chain reaction or antigen during acute infection or by positive antibodies thereafter. We considered PC diagnosis when symptoms remain after COVID-19. We collected the principal characteristics of COVID-19, the severity of fatigue, waking unrefreshed and cognitive impairment, and persistent symptoms. The American College of Rheumatology (ACR) criteria and the Combined Index of Severity in Fibromyalgia (ICAF) were collected in the FM group. RESULTS: RD group (n = 56) had more pneumonia (p = 0.001) and hospital admissions (p = 0.002), but the FM group (n = 78) had a higher number of symptoms (p = 0.002). The percentage of patients with PC was similar between groups (FM group 79.5%; RD group 66.1%, p = 0.081). FM group had more PC symptoms (p = 0.001), more impairment after COVID-19 (p = 0.002) and higher severity of fatigue, waking unrefreshed and cognitive impairment (p <  0.0001). Only loss of smell was more frequent in the FM group (p = 0.005). The FM group with PC (n = 29) showed more severity of the Combined Index of Severity in Fibromyalgia (ICAF) total score and physical factor after COVID-19, while emotional, coping factors and the ACR criteria did not change. CONCLUSIONS: The prevalence of PC in FM patients is similar to RD patients. In FM patients, the presence of PC does not appear to impact the severity of FM.


Subject(s)
Autoimmune Diseases , COVID-19 , Fibromyalgia , Rheumatic Diseases , COVID-19/epidemiology , COVID-19 Testing , Fatigue/diagnosis , Fatigue/epidemiology , Fibromyalgia/diagnosis , Fibromyalgia/epidemiology , Fibromyalgia/psychology , Humans , Prevalence , Retrospective Studies , Rheumatic Diseases/diagnosis , Rheumatic Diseases/epidemiology , Severity of Illness Index , Surveys and Questionnaires
2.
Language Teaching ; 55(3):417-421, 2022.
Article in English | ProQuest Central | ID: covidwho-1908041

ABSTRACT

The researchers noted that whereas most language learning strategies research has accounted for strategies used separately or as part of latent factors, their study participants were found to almost always use strategies in sequences, pairs, and clusters. By analyzing these strategy combinations and their moment-to-moment functions, Cohen and Wang identified six patterns: (1) linear progression in functions (e.g., from metacognitive to cognitive);(2) simultaneous occurrence of functions (e.g., social and affective);(3) linear progression in functions + simultaneous occurrence of functions;(4) bi-directional fluctuation of functions (e.g., back and forth between metacognitive and cognitive);(5) bi-directional fluctuation + simultaneous occurrence of functions;and (6) simultaneous occurrence of functions + micro-fluctuations of functions (see Cohen & Wang, 2018). [...]Gao and Hu drew on an adapted activity system model based on earlier work by Engeström, who expanded on Vygotsky's idea of mediation (see Gao & Hu, 2020). The system has three mediating resources: community (e.g., a social group performing similar actions with similar goals), rules (e.g., time and academic requirements), and division of labor (e.g., roles and power relationships with the community).

3.
Int J Environ Res Public Health ; 19(3)2022 01 29.
Article in English | MEDLINE | ID: covidwho-1686744

ABSTRACT

This article is based on qualitative analysis of interviews and focus groups conducted with participants enrolled in the Senior Programme of the University of Lleida, the City Council of Lleida, and care homes, as well as professional workers in the field of gerontology and related areas. It presents the analysis of interviews focused on the participants' life trajectories, ageing, creativity, self-perception, and quality of life. The study aimed to examine how creativity influences the maintenance and improvement of a sense of wellbeing in older adults, and to reflect on how the perception of old age and of oneself changes through creative activity and active engagement across the life span. The article is framed within a new concept in sociology and the social sciences-'profiguration', which is the key element in the promotion and strengthening of intergenerational interdependence, education, wellbeing, social participation, and active ageing.


Subject(s)
Ageism , Quality of Life , Aged , Aging , Creativity , Humans , Self Concept
4.
Rheumatol Int ; 40(10): 1593-1598, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-713879

ABSTRACT

OBJECTIVE: To describe clinical characteristics of patients with rheumatic and musculoskeletal diseases (RMDs) and immunosuppressive therapies with Coronavirus disease 2019 (COVID-19) at an academic rheumatology center in Madrid and to identify baseline variables associated with a severe infection requiring hospitalization. METHODS: We identified SARS-CoV-2 positive cases by polymerase chain reaction performed at our center within an updated RMDs database in our clinic. Additional RMDs patients were identified when they contacted the clinic because of a positive infection. Data extraction included diagnosis, demographics, immunosuppressive treatment, comorbidities, and laboratory tests. Comparisons between patients with or without hospitalization were performed. Multivariate logistic regression was used to analyze associations between baseline variables and need for hospitalization. RESULTS: A total of 62 patients with COVID-19 and underlying RMDs were identified by April 24, 2020. Median age was 60.9 years, and 42% men. Forty-two patients required hospitalization; these were more frequently men, older and with comorbidities. There were no statistically significant between-group differences for rheumatologic diagnosis and for baseline use of immunosuppressive therapy except for glucocorticoids that were more frequent in hospitalized patients. Total deaths were 10 (16%) patients. In multivariate analysis, male sex (odds ratio [OR], 8.63; p = 0.018), previous lung disease (OR, 27.47; p = 0.042), and glucocorticoids use (> 5 mg/day) (OR, 9.95; p = 0.019) were significantly associated to hospitalization. CONCLUSION: Neither specific RMD diagnoses or exposures to DMARDs were associated with increased odds of hospitalization. Being male, previous lung disease and exposure to glucocorticoids were associated with higher odds of hospitalization in RMDs patients.


Subject(s)
Arthritis, Psoriatic/drug therapy , Arthritis, Rheumatoid/drug therapy , Coronavirus Infections/physiopathology , Glucocorticoids/therapeutic use , Hospitalization/statistics & numerical data , Immunosuppressive Agents/therapeutic use , Lupus Erythematosus, Systemic/drug therapy , Pneumonia, Viral/physiopathology , Aged , Anti-Bacterial Agents/therapeutic use , Antibodies, Monoclonal, Humanized/therapeutic use , Antirheumatic Agents/therapeutic use , Antiviral Agents/therapeutic use , Arthritis, Psoriatic/complications , Arthritis, Psoriatic/epidemiology , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/epidemiology , Autoimmune Diseases/complications , Autoimmune Diseases/drug therapy , Autoimmune Diseases/epidemiology , Azithromycin/therapeutic use , Betacoronavirus , COVID-19 , Comorbidity , Coronavirus Infections/complications , Coronavirus Infections/drug therapy , Coronavirus Infections/mortality , Coronavirus Infections/therapy , Drug Combinations , Female , Humans , Hydroxychloroquine/therapeutic use , Logistic Models , Lopinavir/therapeutic use , Lung Diseases/epidemiology , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/epidemiology , Male , Middle Aged , Multivariate Analysis , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/mortality , Pneumonia, Viral/therapy , Retrospective Studies , Ritonavir/therapeutic use , SARS-CoV-2 , Severity of Illness Index , Sex Factors , Spain/epidemiology , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL